300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Energy
Retail
Oil and Gas
Film
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
Social Network
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Guinea
Haiti
Croatia
Kyrgyzstan
Norway
Iran
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Madagascar
Mexico
Russian Federation
Sudan
Pakistan
Zambia
Tajikistan
Puerto Rico
Romania
Oman
Poland
Cameroon
Guernsey
Armenia
Colombia
China
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Paraguay
Botswana
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Qatar
Angola
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Heidi Kakko, Angel Investor at European Innovation Council

Heidi Kakko

Angel Investor @ European Innovation Council

Heidi Kakko is a Series A investor at European Innovation Council focused on Medical and Health Care. Heidi Kakko leads the Development Fund´s investment division by preparing the investments and developing the whole market.Heidi has been actively participating in financing and acquiring companies since 1995, she worked on business consultation and finance at the world`s biggest consultation company PricewaterhouseCoopers for more than 10years.Before joining the Development Fund, Heidi worked as an M&A Leader at an international investment company East Partners, focusing on the markets of Ukraine, Russia and Georgia. As an executive manager, Heidi has gained experience working at the biggest BTL agency in the Baltics as well as developing one of the first Estonian training companies into a business school.

Total investments:
5
Last investment:
Lead investor:
60%

Last updated:

Industries Heidi Kakko invests in

MedicalHealth CareTherapeuticsBiotechnologyManufacturing

Stages Heidi Kakko invests in

Series AFunding RoundSeed

Countries Heidi Kakko invests in

NorwayEstoniaIrelandSwitzerland

Round sizes

Series A $1.8M–$16M

Contacts

TypeContactValidation
Work email
Personal email
Work phone
Personal phone
Socials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Series A
$1.8M–$16M

Investment Focus

Industry

  • Medical 1 (20%)
  • Health Care 1 (20%)
  • Therapeutics 1 (20%)
  • Biotechnology 1 (20%)
  • Manufacturing 1 (20%)
See all 7 industries →

Stage

  • Series A 2 (40%)
  • Funding Round 2 (40%)
  • Seed 1 (20%)

Country

  • Norway 1 (20%)
  • Estonia 1 (20%)
  • Ireland 1 (20%)
  • Switzerland 1 (20%)

Investments

CompanyDescriptionRoundLinks
Nanordica Medical is an Estonian medical technology company providing the first-line treatment for chronic wounds based on unique patented nanotechnology, a synergy of copper and silver in nanofibers that remove infection and support wound healing.Nanordica Medical launched a veterinary product Ravimus Vet for animal wounds(https://nanordica.com/ravimus.html) and is developing a first-in-class wound dressing for human hard-to-heal wounds like diabetic foot ulcers. They recently completed a clinical trial showing consistently better results in nearly all efficacy parameters observed among the patients treated with the Nanordica wound dressing than those treated with the commercially available silver ions-based active dressing. $1.8M / Venture - Series Unknown / Jun 09, 2026
Nanordica Medical is an Estonian medical technology company providing the first-line treatment for chronic wounds based on unique patented nanotechnology, a synergy of copper and silver in nanofibers that remove infection and support wound healing.Nanordica Medical launched a veterinary product Ravimus Vet for animal wounds(https://nanordica.com/ravimus.html) and is developing a first-in-class wound dressing for human hard-to-heal wounds like diabetic foot ulcers. They recently completed a clinical trial showing consistently better results in nearly all efficacy parameters observed among the patients treated with the Nanordica wound dressing than those treated with the commercially available silver ions-based active dressing. $402.7K / Seed / Jan 10, 2023
Sensibel commercializes ultra-high-sensitivity MEMS microphones based on an optical MEMS technology. $16.1M / Series A / Apr 25, 2022
Positrigo is a company dedicated to the development, production, and sales of dedicated brain positron emission tomography (PET) scanners. $1.8M / Series A / Jul 30, 2021
RemedyBio is an immunology-focused discovery and development company based in Dublin, Ireland. It has pioneered a new approach to understanding the immune system and the discovery of new therapies. $9.4M / Venture - Series Unknown / Jul 20, 2021

Co-Investors

European Innovation Council

About European Innovation Council

VC Fund · Brussels, Belgium

The European Innovation Council aims to support top-class innovators, entrepreneurs, small companies, and researchers with bright ideas. The EIC co-invests alongside private investors in early-stage startups that have ESG impacts.

European Innovation Council Contacts

NameEmailPhoneSocials
Baybars Altuntas
Baybars Altuntas Board Member
Candace Johnson
Candace Johnson President
Jacopo Losso
Jacopo Losso Director of Secretariat
Pablo Hernández
Pablo Hernández IT Expert
Selma Prodanovic
Selma Prodanovic Board Member & Vice President

Sign up to unlock verified contacts

Unlock Contacts

See all 21 contacts →

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Energy
Retail
Oil and Gas
Film
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
Social Network
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Guinea
Haiti
Croatia
Kyrgyzstan
Norway
Iran
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Madagascar
Mexico
Russian Federation
Sudan
Pakistan
Zambia
Tajikistan
Puerto Rico
Romania
Oman
Poland
Cameroon
Guernsey
Armenia
Colombia
China
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Paraguay
Botswana
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Qatar
Angola
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Heidi Kakko invest in?

Heidi Kakko invests primarily in Medical, Health Care and Therapeutics startups, most often at Series A and Funding Round stage. Most of the 5 investments tracked by Shizune back companies in Norway. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What round sizes does Heidi Kakko invest in?

Heidi Kakko typically joins rounds of $1.8M–$16M at Series A. These are whole funding-round sizes, not Heidi Kakko's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Heidi Kakko took part in.

How do I contact Heidi Kakko?

Public channels for Heidi Kakko include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

When did Heidi Kakko last invest?

The most recent investment recorded for Heidi Kakko closed in Jun 2026. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Heidi Kakko Heidi Kakko Find email